Cytokinetic engineering enhances the secretory production of recombinant human lysozyme in Komagataella phaffii.

Microb Cell Fact

Institute of Pharmaceutical Biotechnology, School of Medicine, Zhejiang University, Hangzhou, 310058, China.

Published: June 2024

Background: Human lysozyme (hLYZ) is a natural antibacterial protein with broad applications in food and pharmaceutical industries. Recombinant production of hLYZ in Komagataella phaffii (K. phaffii) has attracted considerable attention, but there are very limited strategies for its hyper-production in yeast.

Results: Here through Atmospheric and Room Temperature Plasma (ARTP)-based mutagenesis and transcriptomic analysis, the expression of two genes MYO1 and IQG1 encoding the cytokinesis core proteins was identified downregulated along with higher hLYZ production. Deletion of either gene caused severe cytokinesis defects, but significantly enhanced hLYZ production. The highest hLYZ yield of 1,052,444 ± 23,667 U/mL bioactivity and 4.12 ± 0.11 g/L total protein concentration were obtained after high-density fed-batch fermentation in the Δmyo1 mutant, representing the best production of hLYZ in yeast. Furthermore, O-linked mannose glycans were characterized on this recombinant hLYZ.

Conclusions: Our work suggests that cytokinesis-based morphology engineering is an effective way to enhance the production of hLYZ in K. phaffii.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11184742PMC
http://dx.doi.org/10.1186/s12934-024-02434-wDOI Listing

Publication Analysis

Top Keywords

production hlyz
12
human lysozyme
8
hlyz production
8
hlyz
7
production
6
cytokinetic engineering
4
engineering enhances
4
enhances secretory
4
secretory production
4
production recombinant
4

Similar Publications

Background: Human lysozyme (hLYZ) is a natural antibacterial protein with broad applications in food and pharmaceutical industries. Recombinant production of hLYZ in Komagataella phaffii (K. phaffii) has attracted considerable attention, but there are very limited strategies for its hyper-production in yeast.

View Article and Find Full Text PDF

The molecular modification, expression, and the antibacterial effects studies of human lysozyme.

Biosci Biotechnol Biochem

April 2024

The Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, Jiangsu, China.

Human lysozyme (hLYZ) has attracted considerable research attention due to its natural and efficient antibacterial abilities and widespread uses. In this study, hLYZ was modified to enhance its enzyme activity and expressed in a Pichia pastoris expression system. A combination mutant HZM(2R-K)-N88D/V110S demonstrated the highest enzyme activity (6213 ± 164 U/mL) in shake flasks, which was 4.

View Article and Find Full Text PDF

Highly efficient expression and secretion of human lysozyme using multiple strategies in Pichia pastoris.

Biotechnol J

November 2023

Key Laboratory of Carbohydrate Chemistry and Biotechnology, School of Biotechnology, Ministry of Education, Jiangnan University, Wuxi, Jiangsu, China.

Article Synopsis
  • Human lysozyme (hLYZ) is gaining traction as an antibacterial agent for food and pharmaceutical use, but sourcing it is restricted.* -
  • Researchers achieved enhanced production of hLYZ in the yeast Pichia pastoris through strategies like optimizing signal sequences and disrupting vacuolar sorting receptors, reaching enzyme activity levels significantly higher than previous strains.* -
  • Their method not only increased yield to 352,000 U/mL using a specialized medium but also presents a cost-effective way to produce hLYZ and could benefit the production of other recombinant proteins.*
View Article and Find Full Text PDF

In human lysozyme (hLYZ) production by Pichia pastoris, the glycerol fed-batch phase was generally implemented under the environment of "oxygen sufficient-glycerol limited" to achieve high cell-density cultivation during the cell growth phase. However, the structural and functional components in P. pastoris cells were irreversible damaged with more and more reactive oxygen species (ROS) accumulation when cells were exposed to the oxygen sufficient environments for long time, leading to a failure of hLYZ expression.

View Article and Find Full Text PDF

A Combinational Strategy for Effective Heterologous Production of Functional Human Lysozyme in .

Front Bioeng Biotechnol

March 2020

State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Engineering Research Center for Bio-enzyme Catalysis, Hubei Key Laboratory of Industrial Biotechnology, College of Life Sciences, Hubei University, Wuhan, China.

Human lysozyme (hLYZ), known for its bacteriolytic activity, is widely applied in the food and pharmaceutical industries as an antimicrobial agent. However, its extensive application was limited by its low large-scale production efficiency. In this study, a combinational method of integrating codon optimization, multiple gene copies, and ER molecular chaperone co-expression was developed to improve the heterologous production of hLYZ in GS115.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!